{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T21:53:06Z","timestamp":1781733186594,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s11934-022-01132-7","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T13:46:07Z","timestamp":1669902367000},"page":"41-50","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Vaginal Hormone Therapy for Conditions of the Lower Urinary Tract"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1726-3424","authenticated-orcid":false,"given":"Amy","family":"Nemirovsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia Arias","family":"Villela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Christine","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena D.","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"issue":"2","key":"1132_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ajog.2019.08.043","volume":"222","author":"KK Crean-Tate","year":"2020","unstructured":"Crean-Tate KK, Faubion SS, Pederson HJ, Vencill JA, Batur P. Management of genitourinary syndrome of menopause in female cancer patients: a focus on vaginal hormonal therapy. Am J Obstet Gynecol. 2020;222(2):103\u201313.","journal-title":"Am J Obstet Gynecol"},{"key":"1132_CR2","doi-asserted-by":"crossref","unstructured":"Blakeman PJ, Hilton P, Bulmer JN. Cellular proliferation in the female lower urinary tract with reference to oestrogen status. BJOG: An International Journal of Obstetrics & Gynaecology. 2001;108(8):813\u20136.","DOI":"10.1111\/j.1471-0528.2001.00210.x"},{"key":"1132_CR3","doi-asserted-by":"crossref","unstructured":"Robinson D, Cardozo LD. The role of estrogens in female lower urinary tract dysfunction. Urology. 2003 Oct 1;62(4, Supplement 1):45\u201351.","DOI":"10.1016\/S0090-4295(03)00676-9"},{"issue":"11","key":"1132_CR4","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1097\/GME.0000000000000910","volume":"24","author":"F Labrie","year":"2017","unstructured":"Labrie F, Archer DF, Martel C, Vaillancourt M, Montesino M. Combined data of intravaginal prasterone against vulvovaginal atrophy of menopause. Menopause. 2017;24(11):1246\u201356.","journal-title":"Menopause"},{"issue":"2","key":"1132_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/2053369119884144","volume":"26","author":"P Briggs","year":"2020","unstructured":"Briggs P. Genitourinary syndrome of menopause. Post Reprod Health. 2020;26(2):111\u20134.","journal-title":"Post Reprod Health"},{"issue":"6","key":"1132_CR6","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1097\/AOG.0000000000000526","volume":"124","author":"DD Rahn","year":"2014","unstructured":"Rahn DD, Carberry C, Sanses TV, Mamik MM, Ward RM, Meriwether KV, et al. Vaginal estrogen for genitourinary syndrome of menopause. Obstet Gynecol. 2014;124(6):1147\u201356.","journal-title":"Obstet Gynecol"},{"issue":"361","key":"1132_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k1315","volume":"25","author":"K Richardson","year":"2018","unstructured":"Richardson K, Fox C, Maidment I, Steel N, Loke YK, Arthur A, et al. Anticholinergic drugs and risk of dementia: case-control study. BMJ. 2018;25(361): k1315.","journal-title":"BMJ"},{"issue":"8","key":"1132_CR8","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1001\/jamainternmed.2019.0677","volume":"179","author":"CAC Coupland","year":"2019","unstructured":"Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic drug exposure and the risk of dementia: a nested case-control study. JAMA Intern Med. 2019;179(8):1084\u201393.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"1132_CR9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/nau.24536","volume":"40","author":"RR Dmochowski","year":"2021","unstructured":"Dmochowski RR, Thai S, Iglay K, Enemchukwu E, Tee S, Varano S, et al. Increased risk of incident dementia following use of anticholinergic agents: a systematic literature review and meta-analysis. Neurourol Urodyn. 2021;40(1):28\u201337.","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"1132_CR10","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00345-002-0301-4","volume":"20","author":"W Stewart","year":"2003","unstructured":"Stewart W, Van Rooyen J, Cundiff G, Abrams P, Herzog A, Corey R, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327\u201336.","journal-title":"World J Urol"},{"issue":"1","key":"1132_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11884-016-0344-9","volume":"11","author":"WS Reynolds","year":"2016","unstructured":"Reynolds WS, Fowke J, Dmochowski R. The burden of overactive bladder on US public health. Curr Bladder Dysfunct Rep. 2016;11(1):8\u201313.","journal-title":"Curr Bladder Dysfunct Rep"},{"issue":"52","key":"1132_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.maturitas.2005.06.014","volume":"15","author":"C Castelo-Branco","year":"2005","unstructured":"Castelo-Branco C, Cancelo MJ, Villero J, Nohales F, Juli\u00e1 MD. Management of post-menopausal vaginal atrophy and atrophic vaginitis. Maturitas. 2005;15(52):46\u201352.","journal-title":"Maturitas"},{"issue":"10","key":"1132_CR13","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/j.0001-6349.2004.00581.x","volume":"83","author":"L Cardozo","year":"2004","unstructured":"Cardozo L, Lose G, McClish D, Versi E. A systematic review of the effects of estrogens for symptoms suggestive of overactive bladder. Acta Obstet Gynecol Scand. 2004;83(10):892\u20137.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1132_CR14","doi-asserted-by":"crossref","unstructured":"Cody JD, Jacobs ML, Richardson K, Moehrer B, Hextall A. Oestrogen therapy for urinary incontinence in post\u2010menopausal women. Cochrane Database of Systematic Reviews [Internet]. 2012 [cited 2020 Mar 21]; Available from: https:\/\/www.readcube.com\/articles\/10.1002\/14651858.CD001405.pub3.","DOI":"10.1002\/14651858.CD001405.pub3"},{"key":"1132_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejogrb.2018.01.002","volume":"222","author":"MG Matarazzo","year":"2018","unstructured":"Matarazzo MG, Caruso S, Giunta G, Valenti G, Sarpietro G, Cianci A. Does vaginal estriol make urodynamic changes in women with overactive bladder syndrome and genitourinary syndrome of menopause? Eur J Obstet Gynecol Reprod Biol. 2018;222:75\u20139.","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"key":"1132_CR16","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Matarazzo MG, Sarpietro G, Fiorito D, Di Pasqua S, Ingrassano S, Panella MM, et al. Intravaginal 6.5\u00a0mg prasterone administration in postmenopausal women with overactive bladder syndrome: A pilot study. Eur J Obstet Gynecol Reprod Biol. 2021 Aug;263:67\u201371. A cohort study showing that a group of postmenopausal women with GSM and OAB symptoms showed improvement in their symptoms after treatment with intravaginal prasterone, without any side effects.","DOI":"10.1016\/j.ejogrb.2021.06.009"},{"key":"1132_CR17","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Coll\u00e0 Ruvolo C, Gabrielli O, Formisano C, Califano G, Manna P, Venturella R, et al. Prasterone in the treatment of mild to moderate urge incontinence: an observational study. Menopause. 2022;29(8):957\u201362. This cohort study showed that intravaginal prasterone may improve the severity of urge urinary incontinence in postmenopausal women with GSM compared with intravaginal hyaluronic acid.","DOI":"10.1097\/GME.0000000000002007"},{"issue":"4","key":"1132_CR18","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/SPV.0000000000000256","volume":"22","author":"DR Ellington","year":"2016","unstructured":"Ellington DR, Szychowski JM, Malek JM, Gerten KA, Burgio KL, Richter HE. Combined tolterodine and vaginal estradiol cream for overactive bladder symptoms after randomized single-therapy treatment. Female Pelvic Med Reconstr Surg. 2016;22(4):254\u201360.","journal-title":"Female Pelvic Med Reconstr Surg"},{"issue":"4","key":"1132_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/GME.0000000000000574","volume":"23","author":"F Jiang","year":"2016","unstructured":"Jiang F, Zhu L, Xu T, Gong MY, Huang YL, Li HF, et al. Efficacy and safety of solifenacin succinate tablets versus solifenacin succinate tablets with local estrogen for the treatment of overactive bladder in postmenopausal women-a multicenter, randomized, open-label, controlled comparison study. Menopause. 2016;23(4):451\u20137.","journal-title":"Menopause"},{"issue":"1","key":"1132_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/2053369116633017","volume":"22","author":"B Chughtai","year":"2016","unstructured":"Chughtai B, Forde JC, Buck J, Asfaw T, Lee R, Te AE, et al. The concomitant use of fesoterodine and topical vaginal estrogen in the management of overactive bladder and sexual dysfunction in postmenopausal women. Post Reprod Health. 2016;22(1):34\u201340.","journal-title":"Post Reprod Health"},{"key":"1132_CR21","doi-asserted-by":"crossref","unstructured":"Abdelbary AM, El-Dessoukey AA, Massoud AM, Moussa AS, Zayed AS, Elsheikh MG, et al. Combined vaginal pelvic floor electrical stimulation (PFS) and local vaginal estrogen for treatment of overactive bladder (OAB) in perimenopausal females. Randomized Controlled Trial (RCT). Urology. 2015 Sep;86(3):482\u20136.","DOI":"10.1016\/j.urology.2015.06.007"},{"issue":"2","key":"1132_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0378-5122(00)00143-2","volume":"36","author":"A Hextall","year":"2000","unstructured":"Hextall A. Oestrogens and lower urinary tract function. Maturitas. 2000;36(2):83\u201392.","journal-title":"Maturitas"},{"issue":"1","key":"1132_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1590\/s1677-5538.ibju.2018.0581","volume":"46","author":"AY Weintraub","year":"2020","unstructured":"Weintraub AY, Glinter H, Marcus-Braun N. Narrative review of the epidemiology, diagnosis and pathophysiology of pelvic organ prolapse. Int braz j urol. 2020;46(1):5\u201314.","journal-title":"Int braz j urol"},{"issue":"1","key":"1132_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000445074","volume":"82","author":"MA Weber","year":"2017","unstructured":"Weber MA, Lim V, Oryszczyn J, te West N, Souget J, Jeffery S, et al. The effect of vaginal oestriol cream on subjective and objective symptoms of stress urinary incontinence and vaginal atrophy: an international multi-centre pilot study. Gynecol Obstet Invest. 2017;82(1):15\u201321.","journal-title":"Gynecol Obstet Invest"},{"issue":"10","key":"1132_CR25","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1097\/GME.0000000000001175","volume":"25","author":"CM Mitchell","year":"2018","unstructured":"Mitchell CM, Reed SD, Guthrie KA. Time to advocate for better science, and better treatments for women. Menopause. 2018;25(10):1065\u20138.","journal-title":"Menopause"},{"issue":"2","key":"1132_CR26","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00404-011-1955-1","volume":"285","author":"G Capobianco","year":"2012","unstructured":"Capobianco G, Donolo E, Borghero G, Dessole F, Cherchi PL, Dessole S. Effects of intravaginal estriol and pelvic floor rehabilitation on urogenital aging in postmenopausal women. Arch Gynecol Obstet. 2012;285(2):397\u2013403.","journal-title":"Arch Gynecol Obstet"},{"key":"1132_CR27","doi-asserted-by":"crossref","unstructured":"Caruso S, Cianci A, Sarpietro G, Matarazzo MG, Panella M, Cianci S. Ultralow 0.03\u200amg vaginal estriol in postmenopausal women who underwent surgical treatment for stress urinary incontinence: Effects on quality of life and sexual function. Menopause. 2020 Feb;27(2):162\u20139.","DOI":"10.1097\/GME.0000000000001446"},{"issue":"1","key":"1132_CR28","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.maturitas.2013.10.018","volume":"77","author":"P L\u00fcthje","year":"2014","unstructured":"L\u00fcthje P, Hirschberg AL, Brauner A. Estrogenic action on innate defense mechanisms in the urinary tract. Maturitas. 2014;77(1):32\u20136.","journal-title":"Maturitas"},{"issue":"12","key":"1132_CR29","doi-asserted-by":"publisher","first-page":"801","DOI":"10.4111\/kju.2011.52.12.801","volume":"52","author":"R Raz","year":"2011","unstructured":"Raz R. Urinary tract infection in postmenopausal women. Korean J Urol. 2011;52(12):801\u20138.","journal-title":"Korean J Urol"},{"issue":"11","key":"1132_CR30","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1056\/NEJM199309093291102","volume":"329","author":"R Raz","year":"1993","unstructured":"Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med. 1993;329(11):753\u20136.","journal-title":"N Engl J Med"},{"issue":"5","key":"1132_CR31","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/S0002-9378(99)70597-1","volume":"180","author":"B Eriksen","year":"1999","unstructured":"Eriksen B. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol. 1999;180(5):1072\u20139.","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"1132_CR32","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1086\/374341","volume":"36","author":"R Raz","year":"2003","unstructured":"Raz R, Colodner R, Rohana Y, Battino S, Rottensterich E, Wasser I, et al. Effectiveness of estriol-containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women. Clin Infect Dis. 2003;36(11):1362\u20138.","journal-title":"Clin Infect Dis"},{"key":"1132_CR33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejogrb.2016.10.018","volume":"207","author":"M Torella","year":"2016","unstructured":"Torella M, Del Deo F, Grimaldi A, Iervolino SA, Pezzella M, Tammaro C, et al. Efficacy of an orally administered combination of hyaluronic acid, chondroitin sulfate, curcumin and quercetin for the prevention of recurrent urinary tract infections in postmenopausal women. Eur J Obstet Gynecol Reprod Biol. 2016;207:125\u20138.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1132_CR34","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Ferrante KL, Wasenda EJ, Jung CE, Adams-Piper ER, Lukacz ES. Vaginal estrogen for the prevention of recurrent urinary tract infection in postmenopausal women: a randomized clinical trial. Female Pelvic Med Reconstr Surg. 2021;27(2):112\u20137. A randomized controlled trial showing an association between vaginal estrogen and lower rate of recurrent UTI, with the ring formulation slightly more effective than the cream.","DOI":"10.1097\/SPV.0000000000000749"},{"key":"1132_CR35","doi-asserted-by":"crossref","unstructured":"\u2022 Rubin* R, Moyneur E, Tjoa ML, Sadiq A, Labrie F, Dury A. MP30\u201315 prevalence of urinary tract infections in women with genitourinary syndrome of menopause and the impact of vaginal prasterone on urinary tract infections. J Urol [Internet]. 2020 Apr [cited 2022 Jul 28];203(Supplement 4). Available from: http:\/\/www.jurology.com\/doi\/10.1097\/JU.0000000000000869.015. Retrospective cohort study showing an association between the use of vaginal prasterone and reduction in recurrent UTI in women with GSM.","DOI":"10.1097\/JU.0000000000000869.015"},{"issue":"2","key":"1132_CR36","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.juro.2011.03.132","volume":"186","author":"SH Berry","year":"2011","unstructured":"Berry SH, Elliott MN, Suttorp M, Bogart LM, Stoto MA, Eggers P, et al. Prevalence of symptoms of bladder pain syndrome\/interstitial cystitis among adult females in the United States. J Urol. 2011;186(2):540\u20134.","journal-title":"J Urol"},{"issue":"12","key":"1132_CR37","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.3390\/diagnostics11122238","volume":"11","author":"Y Akiyama","year":"2021","unstructured":"Akiyama Y. Biomarkers in interstitial cystitis\/bladder pain syndrome with and without Hunner Lesion: a review and future perspectives. Diagnostics (Basel). 2021;11(12):2238.","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"1132_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40266-020-00810-w","volume":"38","author":"A Gracely","year":"2021","unstructured":"Gracely A, Cameron AP. Managing interstitial cystitis\/bladder pain syndrome in older adults. Drugs Aging. 2021;38(1):1\u201316.","journal-title":"Drugs Aging"},{"issue":"10","key":"1132_CR39","doi-asserted-by":"publisher","first-page":"828","DOI":"10.3109\/09513590.2015.1063119","volume":"31","author":"B Gardella","year":"2015","unstructured":"Gardella B, Iacobone AD, Porru D, Musacchi V, Dominoni M, Tinelli C, et al. Effect of local estrogen therapy (LET) on urinary and sexual symptoms in premenopausal women with interstitial cystitis\/bladder pain syndrome (IC\/BPS). Gynecol Endocrinol. 2015;31(10):828\u201332.","journal-title":"Gynecol Endocrinol"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-022-01132-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11934-022-01132-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-022-01132-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T08:44:46Z","timestamp":1675327486000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11934-022-01132-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["1132"],"URL":"https:\/\/doi.org\/10.1007\/s11934-022-01132-7","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"assertion":[{"value":"26 October 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors do not have existing conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights Informed Consent"}}]}}